Venture Capital

2 articles

Diverse group of executives in a modern biotech boardroom discussing genetic sequences and financial data, symbolizing leadership changes and innovation.

STAT Plus Reports on Major Executive Leadership Changes

Dr. Anya Sharma, former head of R&D at BioGen Corp, a major pharmaceutical player, abruptly left her post to become CEO of GenePath, a gene-editing startup that recently secured $150M in Series B fund

David Grossman·June 13, 2026

A symbolic handshake between representatives of General Catalyst and Summa Health, with a modern hospital in the background, signifying a new era of healthcare innovation and financial restructuring.

Health & Medicine

General Catalyst Acquires Summa Health for $515M, Boosting Tech Initiatives

After posting a $43.5 million operating loss in 2023, Summa Health is shedding $850 million in debt, transitioning to a for-profit entity under General Catalyst's ownership. This move sees General Cat

David Grossman·June 1, 2026